| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
MEETINGS
WANT TO PRESENT A POSTER?
There will be an opportunity to present posters on the broad subject area of the symposium, subject to acceptance of a submitted abstract.
Click here for details.
NOT A MEMBER? IT'S FREE...
If you are a member of the RSC or RPS, you join JPAG for free,
and benefit from discounted prices.
Click here for details.
REGISTER NOW...
Delegate fees include registration, documentation, lunch and refreshments.
DELEGATE RATES:
Concession -ONE DAY ONLY : £ 84.00
Member ONE DAY ONLY : £ 175.00
Non member ONE DAY ONLY : £ 245.00
If you have any questions about the meeting, please contact us: events@jpag.org.
Please promote this event for us on your website or social media platform
SUBJECT: JPAG Symposium: The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium - Day 2 / Tuesday 19th May 2026 / Royal Society of Chemistry, London
TITLE OF EVENT: The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium - Day 2
DATE OF EVENT: Tuesday 19th May 2026
EVENT LINK: https://www.jpag.org/192
VENUE: Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BA
VENUE LINK: www.rsc.org/locations-contacts/
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
We are delighted to invite you to the Spring Symposium 2026 on The Chromatographic (Analytical) method life cycle (2026): From cradle to grave (III), co-organised by ChromSoc and JPAG. This exciting event will take place on 18-19th May 2026 at RSC Burlington House, London, UK.
Like previous meetings, it will have a full and exciting topic and speakers program one that has also been purposefully designed to facilitate delegate and exhibitor access to a wide range of scientists, many of whom are leaders in their field.
The meeting seeks to provide a clear insight into successful strategies in critical areas including:
-the new ICHQ14 and ICH Q2 guideline updates, and other guidelines/chapter, such as the BP and JP chapters and upcoming USP<1220>, <1221> and <1225> chapters).
-covering all stages, from method development and robustness using a range of separation techniques (LC, SFC, GC, CE), qualification and validation, transfer and continuous performance monitoring.
-analytical life-cycle management in the Pharmaceutical industry and the latest regulatory expectations, including AQbD and permitted chromatographic method changes according to main Pharmacopoeias.
-holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management
-key elements of the enhanced approach described in ICH Q14, including Analytical Target Profile (ATP), Knowledge Management, Analytical Risk Assessment, and Performance Monitoring, and how they are integrated into a holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management.
-how to leverage a risk-based approach, and balance between the benefits of post-approval flexibility and the resource investments required for implementation of the additional elements.
-proposed strategies to streamline analytical development, resulting in well-understood analytical methods, and simplify lifecycle management.
-Environmental Sustainability considerations and opportunities
-Pharma industry case studies on how implement these advanced method development and lifecycle concepts in the context of a patient-centred approach and a risk-based control strategies.
-Aligning and strengthening the link between the quality attributes of a product and an analytical procedure, and minimising the risks of future changes and impact on the overall product control strategy.
-Predictive modelling and digital tools and how Industry needs to further strengthen the mindset and available skills in statistics.
These presentations will be delivered by highly regarded and experience international speakers from industry, regulators and the chromatography industry who will share their knowledge and experience in applying and implementing the principles of AQbD. We believe the calibre of the speakers, combined with a fully integrated exhibition and vendor presentation programme, will deliver a highly interesting and well attended event. Ultimately the meeting will provide attendees with a unique means of sharing real experiences with other professionals and will provide excellent networking opportunities.
Exhibitor packages
• One exhibition space in exhibition room
• Brochures / publicity materials circulated to all delegates
• 1 attendees registration including lunch & refreshments
• SILVER: Poster slot without flash presentation including presenter registration (2 people in total).
• GOLD: Poster slot with flash presentation including presenter registration & 1 additional attendee (3 people in total).
• PLATINUM: Presentation slot during a Vendor Presentation Session (significant scientific content, relevant to meeting theme, no longer than 20 mins including questions) including presenter registration & 1 additional attendee (3 people in total).
Platinum Sponsorship (2 day)– approx. £2200*
Gold Sponsorship (2 day)– approx. £1800*
Silver Sponsorship (2 day)– approx. £1500*
RETURN TO MEETINGS
Tuesday 19th May 2026
The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium - Day 2
Royal Society of Chemistry, London
We are delighted to invite you to the Spring Symposium 2026 on The Chromatographic (Analytical) method life cycle (2026): From cradle to grave (III), co-organised by ChromSoc and JPAG. This exciting event will take place on 18-19th May 2026 at RSC Burlington House, London, UK.
Like previous meetings, it will have a full and exciting topic and speakers program one that has also been purposefully designed to facilitate delegate and exhibitor access to a wide range of scientists, many of whom are leaders in their field.
The meeting seeks to provide a clear insight into successful strategies in critical areas including:
-the new ICHQ14 and ICH Q2 guideline updates, and other guidelines/chapter, such as the BP and JP chapters and upcoming USP<1220>, <1221> and <1225> chapters).
-covering all stages, from method development and robustness using a range of separation techniques (LC, SFC, GC, CE), qualification and validation, transfer and continuous performance monitoring.
-analytical life-cycle management in the Pharmaceutical industry and the latest regulatory expectations, including AQbD and permitted chromatographic method changes according to main Pharmacopoeias.
-holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management
-key elements of the enhanced approach described in ICH Q14, including Analytical Target Profile (ATP), Knowledge Management, Analytical Risk Assessment, and Performance Monitoring, and how they are integrated into a holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management.
-how to leverage a risk-based approach, and balance between the benefits of post-approval flexibility and the resource investments required for implementation of the additional elements.
-proposed strategies to streamline analytical development, resulting in well-understood analytical methods, and simplify lifecycle management.
-Environmental Sustainability considerations and opportunities
-Pharma industry case studies on how implement these advanced method development and lifecycle concepts in the context of a patient-centred approach and a risk-based control strategies.
-Aligning and strengthening the link between the quality attributes of a product and an analytical procedure, and minimising the risks of future changes and impact on the overall product control strategy.
-Predictive modelling and digital tools and how Industry needs to further strengthen the mindset and available skills in statistics.
These presentations will be delivered by highly regarded and experience international speakers from industry, regulators and the chromatography industry who will share their knowledge and experience in applying and implementing the principles of AQbD. We believe the calibre of the speakers, combined with a fully integrated exhibition and vendor presentation programme, will deliver a highly interesting and well attended event. Ultimately the meeting will provide attendees with a unique means of sharing real experiences with other professionals and will provide excellent networking opportunities.
Exhibitor packages
• One exhibition space in exhibition room
• Brochures / publicity materials circulated to all delegates
• 1 attendees registration including lunch & refreshments
• SILVER: Poster slot without flash presentation including presenter registration (2 people in total).
• GOLD: Poster slot with flash presentation including presenter registration & 1 additional attendee (3 people in total).
• PLATINUM: Presentation slot during a Vendor Presentation Session (significant scientific content, relevant to meeting theme, no longer than 20 mins including questions) including presenter registration & 1 additional attendee (3 people in total).
Platinum Sponsorship (2 day)– approx. £2200*
Gold Sponsorship (2 day)– approx. £1800*
Silver Sponsorship (2 day)– approx. £1500*
The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium - Day 2
Royal Society of Chemistry, London
We are delighted to invite you to the Spring Symposium 2026 on The Chromatographic (Analytical) method life cycle (2026): From cradle to grave (III), co-organised by ChromSoc and JPAG. This exciting event will take place on 18-19th May 2026 at RSC Burlington House, London, UK.
Like previous meetings, it will have a full and exciting topic and speakers program one that has also been purposefully designed to facilitate delegate and exhibitor access to a wide range of scientists, many of whom are leaders in their field.
The meeting seeks to provide a clear insight into successful strategies in critical areas including:
-the new ICHQ14 and ICH Q2 guideline updates, and other guidelines/chapter, such as the BP and JP chapters and upcoming USP<1220>, <1221> and <1225> chapters).
-covering all stages, from method development and robustness using a range of separation techniques (LC, SFC, GC, CE), qualification and validation, transfer and continuous performance monitoring.
-analytical life-cycle management in the Pharmaceutical industry and the latest regulatory expectations, including AQbD and permitted chromatographic method changes according to main Pharmacopoeias.
-holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management
-key elements of the enhanced approach described in ICH Q14, including Analytical Target Profile (ATP), Knowledge Management, Analytical Risk Assessment, and Performance Monitoring, and how they are integrated into a holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management.
-how to leverage a risk-based approach, and balance between the benefits of post-approval flexibility and the resource investments required for implementation of the additional elements.
-proposed strategies to streamline analytical development, resulting in well-understood analytical methods, and simplify lifecycle management.
-Environmental Sustainability considerations and opportunities
-Pharma industry case studies on how implement these advanced method development and lifecycle concepts in the context of a patient-centred approach and a risk-based control strategies.
-Aligning and strengthening the link between the quality attributes of a product and an analytical procedure, and minimising the risks of future changes and impact on the overall product control strategy.
-Predictive modelling and digital tools and how Industry needs to further strengthen the mindset and available skills in statistics.
These presentations will be delivered by highly regarded and experience international speakers from industry, regulators and the chromatography industry who will share their knowledge and experience in applying and implementing the principles of AQbD. We believe the calibre of the speakers, combined with a fully integrated exhibition and vendor presentation programme, will deliver a highly interesting and well attended event. Ultimately the meeting will provide attendees with a unique means of sharing real experiences with other professionals and will provide excellent networking opportunities.
Exhibitor packages
• One exhibition space in exhibition room
• Brochures / publicity materials circulated to all delegates
• 1 attendees registration including lunch & refreshments
• SILVER: Poster slot without flash presentation including presenter registration (2 people in total).
• GOLD: Poster slot with flash presentation including presenter registration & 1 additional attendee (3 people in total).
• PLATINUM: Presentation slot during a Vendor Presentation Session (significant scientific content, relevant to meeting theme, no longer than 20 mins including questions) including presenter registration & 1 additional attendee (3 people in total).
Platinum Sponsorship (2 day)– approx. £2200*
Gold Sponsorship (2 day)– approx. £1800*
Silver Sponsorship (2 day)– approx. £1500*
WANT TO PRESENT A POSTER?
There will be an opportunity to present posters on the broad subject area of the symposium, subject to acceptance of a submitted abstract.
Click here for details.
NOT A MEMBER? IT'S FREE...
If you are a member of the RSC or RPS, you join JPAG for free,
and benefit from discounted prices.
Click here for details.
REGISTER NOW...
Delegate fees include registration, documentation, lunch and refreshments.
DELEGATE RATES:
Concession -ONE DAY ONLY : £ 84.00
Member ONE DAY ONLY : £ 175.00
Non member ONE DAY ONLY : £ 245.00
If you have any questions about the meeting, please contact us: events@jpag.org.
 | Add the meeting to your calendar by clicking on this icon. (if it first downloads, you will need to double-click the download) |
 | Why not share this meeting with your friends? Send link: https://www.jpag.org/192   |
Please promote this event for us on your website or social media platform
SUBJECT: JPAG Symposium: The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium - Day 2 / Tuesday 19th May 2026 / Royal Society of Chemistry, London
TITLE OF EVENT: The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium - Day 2
DATE OF EVENT: Tuesday 19th May 2026
EVENT LINK: https://www.jpag.org/192
VENUE: Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BA
VENUE LINK: www.rsc.org/locations-contacts/
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
We are delighted to invite you to the Spring Symposium 2026 on The Chromatographic (Analytical) method life cycle (2026): From cradle to grave (III), co-organised by ChromSoc and JPAG. This exciting event will take place on 18-19th May 2026 at RSC Burlington House, London, UK.
Like previous meetings, it will have a full and exciting topic and speakers program one that has also been purposefully designed to facilitate delegate and exhibitor access to a wide range of scientists, many of whom are leaders in their field.
The meeting seeks to provide a clear insight into successful strategies in critical areas including:
-the new ICHQ14 and ICH Q2 guideline updates, and other guidelines/chapter, such as the BP and JP chapters and upcoming USP<1220>, <1221> and <1225> chapters).
-covering all stages, from method development and robustness using a range of separation techniques (LC, SFC, GC, CE), qualification and validation, transfer and continuous performance monitoring.
-analytical life-cycle management in the Pharmaceutical industry and the latest regulatory expectations, including AQbD and permitted chromatographic method changes according to main Pharmacopoeias.
-holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management
-key elements of the enhanced approach described in ICH Q14, including Analytical Target Profile (ATP), Knowledge Management, Analytical Risk Assessment, and Performance Monitoring, and how they are integrated into a holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management.
-how to leverage a risk-based approach, and balance between the benefits of post-approval flexibility and the resource investments required for implementation of the additional elements.
-proposed strategies to streamline analytical development, resulting in well-understood analytical methods, and simplify lifecycle management.
-Environmental Sustainability considerations and opportunities
-Pharma industry case studies on how implement these advanced method development and lifecycle concepts in the context of a patient-centred approach and a risk-based control strategies.
-Aligning and strengthening the link between the quality attributes of a product and an analytical procedure, and minimising the risks of future changes and impact on the overall product control strategy.
-Predictive modelling and digital tools and how Industry needs to further strengthen the mindset and available skills in statistics.
These presentations will be delivered by highly regarded and experience international speakers from industry, regulators and the chromatography industry who will share their knowledge and experience in applying and implementing the principles of AQbD. We believe the calibre of the speakers, combined with a fully integrated exhibition and vendor presentation programme, will deliver a highly interesting and well attended event. Ultimately the meeting will provide attendees with a unique means of sharing real experiences with other professionals and will provide excellent networking opportunities.
Exhibitor packages
• One exhibition space in exhibition room
• Brochures / publicity materials circulated to all delegates
• 1 attendees registration including lunch & refreshments
• SILVER: Poster slot without flash presentation including presenter registration (2 people in total).
• GOLD: Poster slot with flash presentation including presenter registration & 1 additional attendee (3 people in total).
• PLATINUM: Presentation slot during a Vendor Presentation Session (significant scientific content, relevant to meeting theme, no longer than 20 mins including questions) including presenter registration & 1 additional attendee (3 people in total).
Platinum Sponsorship (2 day)– approx. £2200*
Gold Sponsorship (2 day)– approx. £1800*
Silver Sponsorship (2 day)– approx. £1500*
RETURN TO MEETINGS
INTERESTED IN THIS EVENT?
We will keep you informed...
We will keep you informed...
All JPAG-hosted meetings award 4 hours of CPD points.
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
We always seek feedback from delegates attending JPAG events through an Evaluation form.
A recent analysis of the results has shown that more than 95% of attendees thought that JPAG meetings were well planned, relevant and met their main objectives, and would recommend JPAG meetings to colleagues
TESTIMONIALS...
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
PAST MEETINGS
Delegates at a symposium held at the Royal Society of Chemistry
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2026 Website © and by Delta Consultancy Services |
|